Research Hub
Curated cancer research categorised as Colon Cancer. View all research →
A Phase III multicenter trial evaluating the combination of nivolumab and ipilimumab in patients with mismatch repair-deficient metastatic colorectal cancer is currently recruiting. Preliminary…
Updated guidelines recommend colorectal cancer screening starting at age 45 for average-risk adults.
A landmark study demonstrates that pembrolizumab combined with standard chemotherapy significantly extends progression-free survival in patients with mismatch repair-deficient colorectal cancer.